Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-03-30

FDA Approved: TRIENTINE HYDROCHLORIDE — Supplemental Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for TRIENTINE HYDROCHLORIDE submitted by Rising Pharma Holdings, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TRIENTINE HYDROCHLORIDE (Trientine hydrochloride)

Snippet

SUPPL AP for TRIENTINE HYDROCHLORIDE (TRIENTINE HYDROCHLORIDE)